Dissemin is shutting down on January 1st, 2025

Published in

Prex S.r.l., Epidemiology Biostatistics and Public Health, 4(15), 2022

DOI: 10.2427/13021

Links

Tools

Export citation

Search in Google Scholar

Human Papilloma Virus (HPV) vaccination in Italy: towards new perspectives and new challenges

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown
Data provided by SHERPA/RoMEO

Abstract

Human Papilloma virus (HPV) is the cause of a sexually transmitted infection which can lead to the development of genital warts, anogenital and oropharyngeal cancers. In Europe, about 90% of HPV-related cancers and 90% of genital warts are estimated to be vaccine preventable each year. In Italy, around 5,000 cases of cancers are due to HPV infections each year. This explains why HPV infection control is considered a public health priority.